Insider Selling: GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Sells $222,145.00 in Stock

GE HealthCare Technologies Inc. (NASDAQ:GEHC) CEO Thomas J. Westrick sold 2,750 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total value of $222,145.00. Following the completion of the transaction, the chief executive officer now owns 17,509 shares in the company, valued at $1,414,377.02. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

GE HealthCare Technologies Trading Up 1.3 %

Shares of GE HealthCare Technologies stock traded up $1.08 during mid-day trading on Friday, hitting $83.40. 1,584,290 shares of the stock were exchanged, compared to its average volume of 3,113,350. The company has a 50-day simple moving average of $79.20 and a 200 day simple moving average of $82.65. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.05. The stock has a market capitalization of $38.07 billion, a price-to-earnings ratio of 24.39, a price-to-earnings-growth ratio of 3.00 and a beta of 1.17. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last issued its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 earnings per share for the quarter, beating the consensus estimate of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion during the quarter, compared to the consensus estimate of $4.88 billion. During the same period in the previous year, the firm posted $0.92 EPS. GE HealthCare Technologies’s revenue was up .5% on a year-over-year basis. Research analysts forecast that GE HealthCare Technologies Inc. will post 4.27 EPS for the current year.

GE HealthCare Technologies Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be issued a $0.03 dividend. This represents a $0.12 annualized dividend and a yield of 0.14%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.51%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of several analyst reports. Redburn Atlantic raised shares of GE HealthCare Technologies to a “strong-buy” rating in a report on Thursday, August 1st. The Goldman Sachs Group began coverage on shares of GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 price objective for the company. Stifel Nicolaus began coverage on shares of GE HealthCare Technologies in a report on Tuesday. They issued a “buy” rating and a $100.00 target price for the company. Bank of America decreased their price target on GE HealthCare Technologies from $94.00 to $86.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 1st. Finally, Mizuho reduced their price objective on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Five investment analysts have rated the stock with a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.58.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of GEHC. Wynn Capital LLC increased its stake in GE HealthCare Technologies by 4.1% during the first quarter. Wynn Capital LLC now owns 3,125 shares of the company’s stock worth $284,000 after acquiring an additional 122 shares during the last quarter. Byrne Asset Management LLC grew its stake in GE HealthCare Technologies by 0.8% during the first quarter. Byrne Asset Management LLC now owns 16,424 shares of the company’s stock worth $1,493,000 after buying an additional 126 shares during the period. WASHINGTON TRUST Co increased its position in shares of GE HealthCare Technologies by 7.7% in the first quarter. WASHINGTON TRUST Co now owns 1,853 shares of the company’s stock worth $168,000 after acquiring an additional 133 shares in the last quarter. Fiduciary Trust Co increased its holdings in GE HealthCare Technologies by 1.8% in the 4th quarter. Fiduciary Trust Co now owns 7,696 shares of the company’s stock valued at $595,000 after purchasing an additional 133 shares in the last quarter. Finally, Quent Capital LLC raised its holdings in shares of GE HealthCare Technologies by 21.3% during the 1st quarter. Quent Capital LLC now owns 780 shares of the company’s stock valued at $71,000 after buying an additional 137 shares during the period. 82.06% of the stock is currently owned by hedge funds and other institutional investors.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.